Expressing support for designation of the month of September as "Clinical Research Innovation Month".

Bill: 113-hres-733
Sponsor: full_name: Rep. Peters, Scott H. [D-CA-52]
Introduced: 2014-09-17
Policy area: Health
Subjects: Commemorative events and holidays

Congressional tributes

Drug safety, medical device, and laboratory regulation

Medical research
Latest action: action_date: 2014-09-19
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2014-09-17
action_desc: Introduced in House
text: <p>Expresses support for the designation of September 2014 as Clinical Research Innovation Month. Honors and recognizes the contributions of Clinical Research Organizations.</p>

tv_txt: IV 113th CONGRESS 2d Session H. RES. 733 IN THE HOUSE OF REPRESENTATIVES September 17, 2014 Mr. Peters of California (for himself, Mr. Vargas , Ms. Matsui , and Ms. Bass ) submitted the following resolution; which was referred to the Committee on Energy and Commerce RESOLUTION Expressing support for designation of the month of September as Clinical Research Innovation Month .

Whereas Clinical Research Organizations (CROs) provide specially designed services which are fundamental to the development of drugs, biologics, and medical devices that improve the general health and well-being of the people of the United States; Whereas CROs have more than doubled in size over the past decade; Whereas the number of studies conducted by CROs has increased by over 500 percent over the past 8 years; Whereas CROs conduct 80 percent of the experimental research for innovative new drugs; Whereas CROs contribute more than 100,000 professional research jobs to the global innovation economy; Whereas these cutting-edge research organizations undertake approximately two-thirds of business activity for biopharmaceutical development, demonstrating their critical involvement in the pharmaceutical, biotech, and medical device industries; Whereas of the 88 new drugs to receive Food and Drug Administration and Emergency Medical Associates approval last year, 85 of them were manufactured by CROs; Whereas CROs research medical solutions to combat diseases such as breast cancer, Alzheimer’s Disease, hepatitis, diabetes, asthma, and hypertension; Whereas CROs have conducted thousands of clinical trials involving over 1,000,000 patients as they strive to tackle the world’s most pressing medical issues through innovative clinical research; and Whereas the month of September would be an appropriate time to designate as Clinical Research Innovation Month : Now, therefore, be it

That the House of Representatives— (1) supports the designation of Clinical Research Innovation Month ; (2) recognizes the considerable contributions of Clinical Research Organizations to the United States; and (3) honors these organizations, which will continue to inspire innovation in future generations.